top of page

Topic

Biomarkers

14 Podcasts on BackTable

NMIBC Tumor Board: Nuances in Management
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 275  •  21 Nov 2025

NMIBC Tumor Board: Nuances in Management

When standard therapy fails, it does not have to be the end of the road for high-risk bladder cancer patients. Modern treatments, biomarkers, and clinical studies have opened up new avenues for treating recurrent non-muscle invasive bladder cancer (NMIBC). The penultimate episode of the 2025 NMIBC Creator Weekend™ series features urologic oncologists Dr. Vignesh Packiam, Dr. Mark Tyson, and Dr. Sarah Psutka discussing how they navigate complex bladder cancer scenarios.

This podcast is supported by:

Ferring Pharmaceuticals

More on Biomarkers

Loading recent podcasts…

Urology

Urology Episode #275

Nov 21, 2025

with Dr. Mark Tyson, Dr. Sarah Psutka, Dr. Vignesh Packiam

NMIBC Tumor Board: Nuances in Management

When standard therapy fails, it does not have to be the end of the road for high-risk bladder cancer patients. Modern...

1,400+ listens

Urology

Urology Episode #269

Oct 28, 2025

with Dr. Jason Hafron, Dr. Ruchika Talwar

Beyond PSA: The Science Driving Smarter Blood Tests

We have relied on PSA for decades, but what’s next in precision screening for prostate cancer? In this episode of...

1,600+ listens

Urology

Urology Episode #267

Oct 21, 2025

with Dr. Mark Tyson, Dr. Suzanne Merrill, Dr. Bogdana Schmidt

Sequencing Therapies in NMIBC Management

New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the...

1,300+ listens

Tumor Board

Tumor Board Episode #30

Oct 7, 2025

with Dr. Mark Tyson, Dr. Sarah Psutka, Dr. Vignesh Packiam

NMIBC Tumor Board: Nuances in Management

When standard therapy fails, it does not have to be the end of the road for high-risk bladder cancer patients. Modern...

1,400+ listens

Urology

Urology Episode #271

Nov 7, 2025

with Dr. Katie Murray, Dr. Sarah Psutka, Dr. Vignesh Packiam

How Biomarkers Enhance Precision Medicine in Non-Muscle Invasive Bladder Cancer

As new genetic and AI-powered tools emerge for bladder cancer screening, are we getting closer to reducing the need for...

1,400+ listens

Urology

Urology Episode #268

Oct 24, 2025

with Dr. Tyler Stewart, Dr. Bogdana Schmidt

Non-Muscle Invasive Bladder Cancer: Role of Medical Oncology

With the introduction of checkpoint inhibitors into non-muscle invasive bladder cancer (NMIBC) management, who’s on...

1,200+ listens

Urology

Urology Episode #264

Oct 10, 2025

with Dr. Anne Schuckman, Dr. Piyush Agarwal, Dr. Bogdana Schmidt

Contemporary Diagnostics in NMIBC: Clinical Insights

How are leading urologic oncologists using advanced biomarkers and artificial intelligence to refine the diagnosis and...

1,400+ listens

Tumor Board

Tumor Board Episode #28

Oct 7, 2025

with Dr. Katie Murray, Dr. Sarah Psutka, Dr. Vignesh Packiam

How Biomarkers Enhance Precision Medicine in Non-Muscle Invasive Bladder Cancer

As new genetic and AI-powered tools emerge for bladder cancer screening, are we getting closer to reducing the need for...

1,400+ listens

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page